UR CTSI Announces 2022 KL2 Awardees

The University of Rochester Clinical and Translational Science Institute (UR CTSI) has awarded four new KL2 Career Development Awards to early-career clinical and translational scientists across the University of Rochester Medical Center. Awardees will soon begin two years of mentored research with KL2 support that is designed to help them obtain further K- or R- awards to advance their careers. This year’s awardees will adapt a behavioral therapy for use with Deaf individuals, test a new treatment regimen for patients with breast cancer that has spread to the brain, map brain pathways to aid surgery, and validate the use of artificial intelligence to support clinical decision making.

Learn more about awardees’ projects.

  • KL2

University Of Rochester

CTSA Program In Action Goals
Goal 1: Train and Cultivate the Translational Science Workforce
Goal 3: Promote the Integration of Special and Underserved Populations in Translational Research Across the Human Lifespan
Goal 5: Advance the Use of Cutting-Edge Informatics